Cytosolic serine hydroxymethyltransferase controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
26 11 2020
Historique:
received: 18 09 2020
accepted: 06 11 2020
revised: 06 11 2020
entrez: 27 11 2020
pubmed: 28 11 2020
medline: 28 4 2021
Statut: epublish

Résumé

Nutrient utilization and reshaping of metabolism in cancer cells is a well-known driver of malignant transformation. Less clear is the influence of the local microenvironment on metastasis formation and choice of the final organ to invade. Here we show that the level of the amino acid serine in the cytosol affects the migratory properties of lung adenocarcinoma (LUAD) cells. Inhibition of serine or glycine uptake from the extracellular milieu, as well as knockdown of the cytosolic one-carbon metabolism enzyme serine hydroxymethyltransferase (SHMT1), abolishes migration. Using rescue experiments with a brain extracellular extract, and direct measurements, we demonstrate that cytosolic serine starvation controls cell movement by increasing reactive oxygen species formation and decreasing ATP levels, thereby promoting activation of the AMP sensor kinase (AMPK) by phosphorylation. Activation of AMPK induces remodeling of the cytoskeleton and finally controls cell motility. These results highlight that cytosolic serine metabolism plays a key role in controlling motility, suggesting that cells are able to dynamically exploit the compartmentalization of this metabolism to adapt their metabolic needs to different cell functions (movement vs. proliferation). We propose a model to explain the relevance of serine/glycine metabolism in the preferential colonization of the brain by LUAD cells and suggest that the inhibition of serine/glycine uptake and/or cytosolic SHMT1 might represent a successful strategy to limit the formation of brain metastasis from primary tumors, a major cause of death in these patients.

Identifiants

pubmed: 33243973
doi: 10.1038/s41419-020-03215-0
pii: 10.1038/s41419-020-03215-0
pmc: PMC7691363
doi:

Substances chimiques

Glycine Hydroxymethyltransferase EC 2.1.2.1
Adenylate Kinase EC 2.7.4.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1012

Références

Nature. 2013 Jan 24;493(7433):542-6
pubmed: 23242140
Nat Metab. 2019 Sep;1(9):861-867
pubmed: 31598584
Front Cell Neurosci. 2019 Sep 13;13:414
pubmed: 31607865
Nat Metab. 2020 Jan;2(1):62-80
pubmed: 32694686
Cancer Res. 2010 Jun 1;70(11):4327-34
pubmed: 20501851
Cell Death Differ. 2017 Aug;24(8):1311-1313
pubmed: 28574507
Cell Death Dis. 2014 Nov 20;5:e1525
pubmed: 25412303
J Biol Chem. 2018 Apr 20;293(16):6039-6051
pubmed: 29487135
Cell Metab. 2016 Jun 14;23(6):1140-1153
pubmed: 27211901
Nat Commun. 2015 Jan 30;6:6137
pubmed: 25635515
J Cell Biol. 2016 Aug 1;214(3):249-57
pubmed: 27458133
Biochemistry. 2018 Dec 26;57(51):6984-6996
pubmed: 30500180
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):984-9
pubmed: 24395782
Mol Biol Cell. 2016 Sep 1;27(17):2662-74
pubmed: 27385336
J Cell Sci. 2012 May 1;125(Pt 9):2115-25
pubmed: 22619229
Dis Markers. 2017;2017:7062517
pubmed: 28260828
Front Mol Neurosci. 2020 Jun 05;13:97
pubmed: 32581708
Oncotarget. 2014 Nov 30;5(22):11004-13
pubmed: 25436979
Neuropharmacology. 2017 Nov;126:70-83
pubmed: 28807674
Cancer Res. 2015 Feb 1;75(3):554-65
pubmed: 25511375
Cancer Manag Res. 2019 Nov 01;11:9331-9338
pubmed: 31802951
Glia. 1988;1(6):366-70
pubmed: 2976396
J Cell Biol. 2020 Jan 6;219(1):
pubmed: 31690618
Oncotarget. 2014 Apr 15;5(7):1779-92
pubmed: 24732040
J Cereb Blood Flow Metab. 2016 Nov;36(11):1929-1941
pubmed: 26661195
Mol Metab. 2020 Mar;33:83-101
pubmed: 31668988
Mol Clin Oncol. 2015 Jan;3(1):217-221
pubmed: 25469298
Nature. 2017 Aug 2;548(7665):122
pubmed: 28770843
Dev Cell. 2016 Mar 7;36(5):540-9
pubmed: 26954548
Int J Cancer. 2015 Mar 1;136(5):E455-69
pubmed: 25227893
Oncotarget. 2016 Jan 26;7(4):4570-83
pubmed: 26717037
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
J Cell Sci. 2012 Nov 1;125(Pt 21):5051-60
pubmed: 22946048
Mol Cancer Res. 2016 Nov;14(11):1087-1096
pubmed: 27578770
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Fluids Barriers CNS. 2018 Oct 19;15(1):30
pubmed: 30340614
FEBS J. 2018 Sep;285(17):3238-3253
pubmed: 30035852
Transl Neurodegener. 2018 Nov 6;7:28
pubmed: 30410750
Oxid Med Cell Longev. 2018 Apr 2;2018:1684827
pubmed: 29805728
Biochim Biophys Acta Bioenerg. 2018 Feb;1859(2):99-109
pubmed: 29097244
Trends Biochem Sci. 2014 Apr;39(4):191-8
pubmed: 24657017
J Biol Chem. 2008 Sep 19;283(38):25846-53
pubmed: 18644786

Auteurs

Amani Bouzidi (A)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Maria Chiara Magnifico (MC)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.
Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Via Orabona 4, 70121, Bari, Italy.

Alessandro Paiardini (A)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Alberto Macone (A)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Giovanna Boumis (G)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Giorgio Giardina (G)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Serena Rinaldo (S)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Francesca Romana Liberati (FR)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Clotilde Lauro (C)

Department of Physiology and Pharmacology V. Erspamer, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Cristina Limatola (C)

Department of Physiology and Pharmacology V. Erspamer, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Chiara Lanzillotta (C)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Antonella Tramutola (A)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Marzia Perluigi (M)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy.

Gianluca Sgarbi (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.

Giancarlo Solaini (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.

Alessandra Baracca (A)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.

Alessio Paone (A)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy. alessio.paone@uniroma1.it.

Francesca Cutruzzolà (F)

Department of Biochemical Sciences A. Rossi Fanelli, Laboratory Affiliated to Istituto Pasteur Italia, Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy. francesca.cutruzzola@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH